Corresponding author and ISB President Dr. Jim Heath and lead author Dr. Yapeng Su.

For Cancer Cells, There Is More Than One Path to Drug Resistance

In findings published in the journal Nature Communications, researchers show that cancer cells can take more than one path to reach a drug-resistant cell state. These findings could have promising implications for the future of cancer care.

For Cancer Cells, There Is More Than One Path to Drug Resistance
For Cancer Cells, There Is More Than One Path to Drug Resistance

New Method to Detect, Analyze Rare T Cells Another Step Toward Personalized Cancer Vaccines

Members of ISB’s Heath Lab and their collaborators have developed a way to sensitively detect and analyze neoantigen-specific T-cell populations from tumors and blood. This promising development may have implications for creating targeted, individual-specific cancer vaccines.

New Method to Detect, Analyze Rare T Cells Another Step Toward Personalized Cancer Vaccines
New Method to Detect, Analyze Rare T Cells Another Step Toward Personalized Cancer Vaccines
1 2